Systemic Inflammatory Biomarkers as Prognostic Indicators in Metastatic Colorectal Cancer: A Retrospective Study
Authors:
- Diana-Ioana PanaiteDPDiana-Ioana Panaite
- Simona-Ruxandra VolovatSVSimona-Ruxandra Volovat
- Madalina OstafeMOMadalina Ostafe
- Cezara-Ioana LitcanuCLCezara-Ioana Litcanu
- Cristian-Constantin VolovatCVCristian-Constantin Volovat
- Maria-Luiza BaeanMBMaria-Luiza Baean
- Ingrid-Andrada VasilacheIVIngrid-Andrada Vasilache
- Constantin VolovatCVConstantin Volovat
Open Access
Abstract
Background and Objectives: Systemic inflammatory biomarkers have emerged as potential prognostic indicators in metastatic colorectal cancer (mCRC). However, the prognostic robustness of inflammatory indices such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP), C-reactive protein-to-albumin ratio (CAR), and Glasgow Prognostic Score (GPS) remains incompletely characterized. In this study, we aimed to evaluate the prognostic significance of NLR, PLR, CRP, CAR, and GPS for progression-free survival in metastatic colorectal cancer in a cohort of patients from Romania. Materials and Methods: This retrospective observational study included 148 patients diagnosed with mCRC. Inflammatory biomarkers were determined from baseline laboratory parameters. Progression-free survival (PFS) was the primary endpoint. Statistical analyses included correlation testing, Kaplan–Meier survival analysis, Cox proportional hazards regression, Firth penalized Cox regression, restricted cubic spline modeling, time-dependent receiver operating characteristic (ROC) analysis, LASSO penalized regression, multiple imputation, and parsimonious multivariable Cox models adjusted for major clinicopathologic confounders. Results: Median PFS was 21 months (95% CI 19–24). In univariable Cox analyses, elevated NLR (HR 1.98, 95% CI 1.11–3.51, p = 0.020), PLR (HR 1.89, 95% CI 1.25–2.85, p = 0.002), CRP (HR 1.45, 95% CI 1.15–1.83, p = 0.002), and CAR (HR 1.44, 95% CI 1.05–1.98, p = 0.022) were associated with shorter PFS. Restricted cubic spline analysis demonstrated a significant nonlinear association between NLR and PFS (p = 0.0025). After multiple imputation, NLR remained associated with shorter PFS (HR 2.04, 95% CI 1.13–3.68, p = 0.018). However, in a multivariable model adjusted for major clinicopathologic confounders, this association was not retained (HR 1.41, 95% CI 0.81–2.43, p = 0.221) and time-dependent ROC analyses demonstrated its limited discriminatory performance. Conclusions: Although some inflammatory markers were associated with shorter PFS in univariable analyses, the prognostic effect of NLR was attenuated after adjustment and was not consistently confirmed across all analyses.Keywords
This publication has 42 references indexed in Scilit:
- Prognostic value of routine blood biomarkers in 3-year survival of resectable colorectal cancer patients: a prognostic nomogram for clinical practiceInternational Journal of Colorectal Disease, 2025
- Optimal cutpoint of preoperative neutrophil–lymphocyte ratio and associated postoperative prognosis in colorectal cancer patientsInternational Journal of Colorectal Disease, 2025
- A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancerCancer Medicine, 2022
- Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort studyJournal of Cachexia, Sarcopenia and Muscle, 2021
- The prognostic utility of pre‐treatment neutrophil‐to‐lymphocyte‐ratio (NLR) in colorectal cancer: A systematic review and meta‐analysisCancer Medicine, 2021
- Validation of the conventional Glasgow Prognostic Score and development of the improved Glasgow Prognostic Score in patients with stage 0‐III colorectal cancer after curative resectionAnnals of Gastroenterological Surgery, 2021
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Prognostic value of serum inflammatory markers in colorectal cancerInternational Journal of Colorectal Disease, 2020
- Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysisInternational Journal of Cancer, 2013
- Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively?International Journal of Colorectal Disease, 2012